TGA
CARM

TPG GP A’s Carisma Therapeutics CARM Stock Holding History

TPG GP A’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-561,442
Closed -$551K – 33
2024
Q3 		$551K Sell
561,442
-280,589
-33% -$304K 0.01% 35
2024
Q2 		$1.28M Sell
842,031
-609,850
-42% -$910K 0.02% 32
2024
Q1 		$3.3M Sell
1,451,881
-232,181
-14% -$558K 0.06% 32
2023
Q4 		$4.93M Hold
1,684,062
– – 0.08% 34
2023
Q3 		$7.12M Hold
1,684,062
– – 0.12% 34
2023
Q2 		$14.8M Hold
1,684,062
– – 0.22% 34
2023
Q1 		$5.22M Buy
+1,684,062
New +$16M 0.09% 35

Other funds holding CARM

MC
Merck & Co Rahway, New Jersey $526M AUM 175.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TPG GP A's CARM Position: Q4 2024 in Review

TPG GP A sold out of Carisma Therapeutics (CARM) in Q4 2024, closing a stake of 561,442 shares — an estimated $551K sold.

TPG GP A first reported a position in CARM in Q1 2023 and held it in 7 quarters. The position peaked at $14.8M in Q2 2023. 41 funds tracked by Wall St. Rank hold CARM as of Q4 2024.

  • TPG GP A reported no remaining Carisma Therapeutics position as of Q4 2024 after selling out during the quarter.
  • TPG GP A sold 561,442 Carisma Therapeutics shares in Q4 2024, an estimated $551K.
  • TPG GP A first reported a position in Carisma Therapeutics in Q1 2023 and held it in 7 quarters.
  • TPG GP A's Carisma Therapeutics position peaked at $14.8M in Q2 2023.
  • 41 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2024.

Based on TPG GP A's 13F filing for Q4 2024, filed 14 Feb 2025.